As WHO CNS5 emphasizes molecular aspects of CNS tumor diagnosis, we believe this result strengthens the potential use of palladin as a tool for molecular diagnosis and differentiation of adult gliomas. The gene discussed is PALLD; the disease is central nervous system cancer.